glp-1 prescriptions q1 2025 growth Obesity Market GLP-1 Agonists Weight Loss Drugs

Semaglutide GLP-1 works by mimicking the effects of a natural hormone in your body that regulates appetite

Wegovy is moving toward PBS coverage for a limited group of people with obesity plus established cardiovascular disease, but broad subsidy for obesity alone is not here yet

Surging focus on developing personalized therapies is expected to offer lucrative opportunities in the market during the forecast period

However, a long-term exploratory RCT in 150 people with obesity found that differences in eating disorders psychopathology scores were not maintained at 52 weeks when liraglutide in combination with behavioral therapy was compared with behavioral therapy alone 215

J., Fiorentino T